Home Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension
Article
Licensed
Unlicensed Requires Authentication

Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension

  • Hui Song , Weiguo Bao , Haibin Wang , Guipeng An , Jinbo Feng , Rong Wang , Yun Zhang and Fengshuang An
Published/Copyright: March 1, 2008
Become an author with De Gruyter Brill

Abstract

Background: Endothelial dysfunction plays a significant role in the pathogenesis of essential hypertension (EH). This trial was undertaken to reveal the effects of extended-release felodipine on endothelial vasoactive substances in EH patients.

Methods: A colorimetric chemical method was employed to measure the level of nitric oxide (NO) and nitric oxide synthase (NOS), while radioimmunoassay was employed to measure endothelin (ET), angiotensin-II (Ang-II), thromboxane A2 (TXA2) and prostacyclin I2 (PGI2) in plasma of the subjects. Group 1 consisted of 120 patients who were treated with a 4-week mono-therapy of felodipine. Group 2 consisted of 70 patients who were participating in fitness programs during this period. Another group comprising 80 individuals was selected as controls. Data from both the starting point and the ending point were collected and analyzed.

Results: After a 4-week mono-therapy of extended-release felodipine in Group 1, the levels of plasma ET, Ang-II and TXA2 decreased significantly, while levels of NO, NOS and PGI2 did not noticeably change. In Group 2, there were almost no changes in levels of ET, Ang-II, TXA2, NO, NOS and PGI2.

Conclusions: From these results, we conclude that felodipine reduced blood pressure by decreasing the secretion of ET, Ang-II and TXA2. Consequently, felodipine can revitalize the endothelial function in EH patients.

Clin Chem Lab Med 2008;46:393–5.


Corresponding author: Fengshuang An, MD, PhD, Shandong University, Qilu Hospital, Jinan, No. 107, Wen Hua Xi Road, Jinan, Shandong, 250012, PR China Phone: +86-137-91122759, Fax: +86-531-86169356,

Received: 2007-9-18
Accepted: 2007-11-27
Published Online: 2008-03-01
Published in Print: 2008-03-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Genetics and Molecular Diagnostics
  2. A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry
  3. An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls
  4. Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy
  5. Suitability of the PAXgene™ system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia
  6. Genetic polymorphisms of alcohol metabolising enzymes: their role in susceptibility to oesophageal cancer
  7. 5′ ins/del and 3′ VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease
  8. General Clinical Chemistry and Laboratory Medicine
  9. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties
  10. Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity – possible application in clinical studies on dietary antioxidants
  11. Thyroid-related autoantibodies in Tunisian patients with coeliac disease
  12. A dried serum spot assay for vitamin B12
  13. Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers
  14. Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients
  15. Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula
  16. Gallstone analysis using Fourier transform infrared spectroscopy (FT-IR)
  17. Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy
  18. Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease
  19. Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension
  20. Reference Values
  21. Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients
  22. Infrequency of low red blood cell (RBC) folate levels despite no folate fortification program: a study based on results from routine requests for RBC folate
  23. Validation and Outcome Studies
  24. A new serum cystatin C-based equation for assessing glomerular filtration rate in liver transplantation
  25. Development of des-γ-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer
  26. Letters to the Editor
  27. High oxygen-affinity hemoglobin variant associated with high-level venous oxygen saturation
  28. Interference in urinary free cortisol determination by components of the NuvaRing® contraceptive device
  29. The neutral protease chymase degrades apolipoprotein E from high-density lipoproteins
  30. Unclear results in the article by Wolff and Gerritzen in Clin Chem Lab Med 2007;45(7):917–922
  31. Potassium report of hemolyzed serum samples
  32. Reply to the letter by Carraro: appropriate actions in the detection of haemolytic specimens
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.081/html
Scroll to top button